24 May 2013
Keywords: biochem, pharma, troxatyl, starts, ph, iii, aml
Article | 05 April 2001
BioChem Pharma has started an exploratory Phase III study of Troxatyl(troxacitabine) in previously-untreated patients with acute myelogenous
leukemia as ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
23 May 2013
© 2013 thepharmaletter.com